文献速递主动脉疾病

编辑精选——多中心随机对照试验评估血管腔内主动脉瘤修复术中预防性肠系膜下动脉栓塞对动脉瘤囊变化的影响

Editor's Choice - Multicentre Randomised Controlled Trial to Evaluate the Efficacy of Pre-emptive Inferior Mesenteric Artery Embolisation during Endovascular Aortic Aneurysm Repair on Aneurysm Sac Change.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2025-04-17

CLARIFY IMA多中心随机对照试验在24个中心纳入138例腹主动脉瘤患者,随机分为预防性肠系膜下动脉栓塞组(n=70)与对照组(n=68),评估EVAR术后动脉瘤囊体积变化。12个月时两组囊体积变化无统计学显著差异(栓塞组平均-3.90±14.19% vs 对照组平均-3.56±13.91%,p=.89),T2EL、再干预率及总生存率在各随访时间点亦无统计学显著差异。

要点

  • 预防性IMA栓塞在12个月时动脉瘤囊体积变化与对照组无统计学显著差异(p=.89)。
  • T2EL发生率、免于再干预率及总生存率在各随访时间点均无统计学显著差异。
  • 作者认为需进一步研究以全面评估预防性IMA栓塞对EVAR术后临床结局的影响。

核心结论

  • 预防性IMA栓塞与对照组相比,在24个月随访时未显著影响动脉瘤囊体积变化、T2EL或再干预率。
  • 作者认为可能需进一步研究以全面评估预防性IMA栓塞对EVAR术后临床结局的影响。

研究设计与样本

  • CLARIFY IMA研究为在24个中心开展的多中心随机对照试验,注册于UMIN临床试验注册库(UMIN000035502)。
  • 纳入138例梭形腹主动脉瘤患者,随机分为EVAR联合预防性IMA栓塞组(n=70)或对照组(n=68)。
  • 患者平均年龄±标准差为76±8岁,其中117例为男性。
  • 主要结局为12个月时CT评估的动脉瘤囊体积百分比变化,次要结局包括6、12、24个月时囊直径变化、T2EL发生率、免于再干预率及总生存率。
  • 所有CT数据均在核心实验室使用三维工作站评估。

主要发现

  • IMA栓塞在70例患者中63例(90%)成功,无不良事件发生。
  • 12个月时栓塞组动脉瘤囊体积变化平均为-3.90±14.19%,对照组平均为-3.56±13.91%,两组间无统计学显著差异(p=.89)。
  • 囊直径变化、T2EL发生率、免于再干预率及总生存率在任何随访时间点均无统计学显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 作者认为可能需进一步研究以全面评估预防性IMA栓塞对EVAR术后临床结局的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Persistent type II endoleak (T2EL) following endovascular aortic aneurysm repair (EVAR) has been identified as a cause of aneurysm sac expansion, leading to re-intervention and aneurysm rupture. The role of pre-emptive inferior mesenteric artery (IMA) embolisation to prevent T2EL and sac expansion remains controversial. This study aimed to evaluate the influence of IMA embolisation on aneurysm sac change after EVAR. METHODS: The CLARIFY IMA study was a multicentre randomised controlled trial conducted at 24 centres and was registered in the UMIN Clinical Trials Registry (UMIN000035502). Patients with a fusiform abdominal aortic aneurysm (AAA) were randomised to undergo EVAR with or without pre-emptive IMA embolisation. The primary outcome was the percentage change in computed tomography (CT) assessed aneurysm sac volume at 12 months, with secondary outcomes including sac diameter changes, prevalence of T2EL, freedom from re-intervention, and overall survival at six, 12, and 24 months. All CT data were evaluated at the core laboratory using a 3D workstation. RESULTS: One hundred and thirty-eight patients with AAA (mean age ± standard deviation 76 ± 8 years; 117 men) were randomised to the IMA embolisation (n = 70) or control groups (n = 68). IMA embolisation was successful in 63 (90%) of 70 patients, without any adverse events. At 12 months there was no statistically significant difference in aneurysm sac volume change between the embolisation group (mean -3.90 ± 14.19%) and control group (mean -3.56 ± 13.91%) (p = .89). Furthermore, no statistically significant differences were observed in sac diameter change, rates of T2EL, freedom from re-intervention, and overall survival at any follow up time point. CONCLUSION: Pre-emptive IMA embolisation did not significantly impact the change in aneurysm sac volume, T2EL or re-intervention rates compared with controls at 24 month follow up. Further research may be necessary to fully assess the impact of pre-emptive IMA embolisation on clinical outcomes following EVAR.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ichihashi S, Takahara M, Fujimura N, et al. Editor's Choice - Multicentre Randomised Controlled Trial to Evaluate the Efficacy of Pre-emptive Inferior Mesenteric Artery Embolisation during Endovascular Aortic Aneurysm Repair on Aneurysm Sac Change. Eur J Vasc Endovasc Surg. 2025. PMID: 40252952. doi:10.1016/j.ejvs.2025.04.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。